Epigenetics Archives

October 10, 2024 Disrupting Asxl1 gene prevents T-cell exhaustion, improving immunotherapy

MEMPHIS, Tenn. (Oct. 10, 2024) — Immunotherapy, using a patient’s own immune system to treat disease, has shown promise in some patients with cancer but…

August 29, 2024 New anti-cancer ‘degrader’ targets protein essential to infant leukemia

GRAND RAPIDS, Mich. (Aug. 29, 2024) — Scientists at Van Andel Institute and Icahn School of Medicine at Mount Sinai have developed…

June 27, 2024 Epigenetics expert Dr. Derek Janssens joins Van Andel Institute

GRAND RAPIDS, Mich. (June 27, 2024) — Van Andel Institute has recruited epigenetics expert Derek Janssens, Ph.D., whose leading-edge research explores the nuanced factors that…

June 26, 2024 New research aims to improve cancer immunotherapy

To say that immunotherapies have been a game-changer for cancer feels like an incredible understatement.

These powerful treatments, which work by bolstering the immune…

May 30, 2024 Van Andel Institute establishes new endowed chairs, names renowned scientists as inaugural appointees

GRAND RAPIDS, Mich. (May 30, 2024) — Van Andel Institute has named Peter W. Laird, Ph.D., as the Peter and Emajean Cook Endowed Chair in…

May 20, 2024 For some endometriosis-related ovarian cancers, timing is everything

GRAND RAPIDS, Mich. (May 20, 2024) — Two types of endometriosis-related ovarian cancer arise from the same cells but likely at different stages of the menstrual cycle…

March 27, 2024 Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types

GRAND RAPIDS, Mich. (March 27, 2024) — A pair of medications that make malignant cells act as if they have a virus could hold new promise for…

March 6, 2024 Van Andel Institute announces 2024 Public Lecture Series

GRAND RAPIDS, Mich. (March 6, 2024) — Van Andel Institute’s free Public Lecture Series returns March 20. This year’s lineup tackles topics such as cancer and nutrition,…